Healthcare & Life Sciences Transactions
News & Insights for Public Companies
- Kirkland Advises Apogee Therapeutics on $10.9 Billion Sale to Abbvie
- Kirkland Advises Eli Lilly on Acquisition of LimmaTech Biologics
- Kirkland Advises Catalyst Pharmaceuticals on $4.1 Billion Sale to Angelini
- Kirkland Advises KalVista on $1.9 Billion Acquisition by Chiesi
- Kirkland Advises Eli Lilly on Acquisition of Kelonia Therapeutics
- Kirkland Advises Eli Lilly on Agreement to Acquire Centessa Pharmaceuticals for up to $7.8 Billion
- Kirkland Advises Danaher on $9.9 Billion Acquisition of Masimo
- Kirkland Advises Amicus Therapeutics on $4.8 Billion Sale to BioMarin
- Kirkland Advises Kestra Medical Technologies, Ltd. on Upsized Primary Public Offering of Common Shares